Subscribe
Logo small
Search
banner

AOTMiT: Transparency Council to evaluate drugs for drug-resistant epilepsy and melanoma, among others

MedExpress Team

medexpress.pl

Published April 12, 2024 08:57

AOTMiT: Transparency Council to evaluate drugs for drug-resistant epilepsy and melanoma, among others - Header image
Źródło: AOTMiT
On Monday, April 15, the next meeting of the Transparency Council.

The agenda includes:

1 Prepare a position paper on qualifying health care services: Branched-chain amino acids in "dry" blood drop; Amino acid profile in plasma/serum or urine; Amino acid and acylcarnitine profile in "dry" blood drop; Organic acid profile in urine GC/MS; Succinylacetone in "dry" blood drop; Total homocysteine, methylmalonic acid and methylcitric acid in "dry" blood drop; Pterins in urine" as guaranteed benefits.

2 Prepare a position paper on the legitimacy of issuing approvals for reimbursement of medicinal products Petinimid, Petnidan/Petnidan Saft (ethosuximidum) in the indication: drug-resistant epilepsy (including epilepsy with absence seizures), continuous discharge syndrome in slow-wave sleep.

3 Prepare an opinion on the inclusion in reimbursement of medicinal products containing the active substance pembrolizumabum within th...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also